INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 22 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $363,000 | -9.7% | 721,046 | 0.0% | 0.00% | – |
| Q4 2019 | $402,000 | -48.5% | 721,046 | -1.2% | 0.00% | – |
| Q3 2019 | $781,000 | -29.5% | 730,130 | -23.6% | 0.00% | – |
| Q2 2019 | $1,108,000 | -31.2% | 955,144 | +14.5% | 0.00% | – |
| Q1 2019 | $1,610,000 | +33.7% | 834,040 | +60.1% | 0.00% | – |
| Q4 2018 | $1,204,000 | -45.6% | 520,954 | +60.6% | 0.00% | – |
| Q3 2018 | $2,215,000 | +41.1% | 324,315 | +387.1% | 0.00% | – |
| Q2 2018 | $1,570,000 | – | 66,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |